METTL3淘汰赛通过抑制内分泌网膜应激反应加速肝癌发生
1Biotherapy Centre, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
FEBS open bio
|March 19, 2025
概括
与之前的研究相反,METTL3损失通过影响RNA甲基化促进肝细胞癌 (HCC) 的启动,这与之前的研究相反. 这表明METTL3在早期肝癌中起到瘤抑制作用.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- N6-甲基氨酸 (m6A) 修饰在RNA生物学中至关重要,并与HCC有关.
- 以前的研究表明,METTL3在肝癌中起着致癌作用.
研究的目的:
- 使用肝脏特异性淘汰赛小鼠模型研究METTL3在HCC启动中的作用.
- 阐明METTL3在肝癌发生过程中的功能背后的分子机制.
主要方法:
- 生产肝脏特异性的条件METTL3淘汰小鼠.
- 在各种瘤挑战下诱导肝脏瘤.
- 对m6A沉积,MANF转录水平和内质网膜 (ER) 应激反应的分析.
主要成果:
- 在小鼠中,METTL3的丧失显著促进了肝脏瘤的开始.
- METTL3缺陷减少了MANF转录中的m6A,影响了核出口和MANF蛋白水平.
- 这导致ER应激反应激活不足,加速HCC启动.
结论:
- 在HCC的早期阶段,METTL3起着抑制瘤的作用.
- 这些发现突显了像METTL3这样的表观遗传调节剂在癌症中的动态和上下文依赖的作用.
- 了解METTL3的功能对于开发向的HCC疗法至关重要.
相关概念视频
The Unfolded Protein Response
4.3K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.3K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K


